Constellation Brands press release ( STZ ): Q4 Non-GAAP EPS of $1.90 beats by $0.19. Revenue of $1.92B (-11.1% Y/Y) beats by $40M. Q1 Revenue consensus of $2.39b Q1 EPS consensus of $3.35 FY EPS consensus of $11.63 FY Revenue consensus of $9.09B More on Constellation Brands Constellation Brands: Red Flags On Beer Metrics Constellation Brands: Looking At Cheap Consumer Products Constellation Brands...
Constellation Brands press release ( STZ ): Q4 Non-GAAP EPS of $1.90 beats by $0.19. Revenue of $1.92B (-11.1% Y/Y) beats by $40M. Q1 Revenue consensus of $2.39b Q1 EPS consensus of $3.35 FY EPS consensus of $11.63 FY Revenue consensus of $9.09B More on Constellation Brands Constellation Brands: Red Flags On Beer Metrics Constellation Brands: Looking At Cheap Consumer Products Constellation Brands: A Transition Year, But The Valuation Looks Compelling Constellation Brands Q4 2026 Earnings Preview Quant snapshot: Delta Air Lines leads top-rated names as Byrna Technologies, Simulations Plus lag
Paul Solway ignited explosion that damaged total of six terrace houses in Derby after his partner had kicked him out A man who blew up a terrace house by causing gas to leak from a pipe and setting fire to a chair after his partner kicked him out has been jailed for 11 years. Paul Solway was having a “meltdown” when he caused the explosion at his partner Joanne Waterfall’s home in Alvaston in Derb...
Paul Solway ignited explosion that damaged total of six terrace houses in Derby after his partner had kicked him out A man who blew up a terrace house by causing gas to leak from a pipe and setting fire to a chair after his partner kicked him out has been jailed for 11 years. Paul Solway was having a “meltdown” when he caused the explosion at his partner Joanne Waterfall’s home in Alvaston in Derby on the evening of 10 June last year. Continue reading...
All three of the major indexes (^DJI, ^IXIC, ^GSPC) closed Wednesday's session with colossal gains — the Dow Jones Industrial Average skyrocketed by over 1,320 points (2.85%) and the Nasdaq Composite surged by nearly 620 points (2.8%) — after President Trump announced that Iran agreed to a two-week ceasefire last night. Yahoo Finance Markets and Data Editor Jared Blikre takes a closer look at the ...
All three of the major indexes (^DJI, ^IXIC, ^GSPC) closed Wednesday's session with colossal gains — the Dow Jones Industrial Average skyrocketed by over 1,320 points (2.85%) and the Nasdaq Composite surged by nearly 620 points (2.8%) — after President Trump announced that Iran agreed to a two-week ceasefire last night. Yahoo Finance Markets and Data Editor Jared Blikre takes a closer look at the trading day's biggest sector gainers.
alvarez/E+ via Getty Images Shares of Vital Farms ( VITL ) spent nearly all of Thursday in negative territory as a result of TD Cowen’s downgrade to Hold from Buy, along with a deep cut to its price target. Analyst Robert Moskow now sees the stock retreating to $16 per share, a 36% cut from the prior price target. “We lower Vital Farms to Hold as the slowdown in VITL’s retail sales trends has alre...
alvarez/E+ via Getty Images Shares of Vital Farms ( VITL ) spent nearly all of Thursday in negative territory as a result of TD Cowen’s downgrade to Hold from Buy, along with a deep cut to its price target. Analyst Robert Moskow now sees the stock retreating to $16 per share, a 36% cut from the prior price target. “We lower Vital Farms to Hold as the slowdown in VITL’s retail sales trends has already caused the stock’s valuation multiple to contract and short interest remains elevated,” Moskow said. However, the analyst will remain on the sidelines until there is more clarity on whether the causes of the slowdown are transitory or more enduring. Wall Street is mostly bullish on Vital Farms ( VITL ) with Seeking Alpha authors viewing the stock as a Buy and Wall Street analysts seeing Vital Farms ( VITL ) as a Strong Buy. Seeking Alpha’s Quant score, however, gives the stock a Strong Sell rating with a Quant score of just 1.09 out of 5, giving failing grades on momentum and revisions. More on Vital Farms Vital Farms: The Egg Story Isn't Broken Vital Farms Still Plans To Sell Many More Eggs Vital Farms, Inc. 2025 Q4 - Results - Earnings Call Presentation Small-cap consumer staples stocks: top and bottom quant picks post earnings Most and least shorted consumer staples with up to $2B market cap at February end
Roman Tiraspolsky SA analysts expressed skepticism about the run-up in Intel ( INTC ) shares this week amid news the company was joining Elon Musk's Terafab AI chip project. Intel announced on X early Tuesday that it was joining the venture, which also includes Musk's SpaceX ( SPACE ), xAI ( X.AI ), and Tesla ( TSLA ). "Our ability to design, fabricate, and package ultra-high-performance chips at ...
Roman Tiraspolsky SA analysts expressed skepticism about the run-up in Intel ( INTC ) shares this week amid news the company was joining Elon Musk's Terafab AI chip project. Intel announced on X early Tuesday that it was joining the venture, which also includes Musk's SpaceX ( SPACE ), xAI ( X.AI ), and Tesla ( TSLA ). "Our ability to design, fabricate, and package ultra-high-performance chips at scale will help accelerate Terafab’s aim to produce 1 TW/year of compute to power future advances in AI and robotics," Intel said in its post. News of the Terafab agreement helped push Intel shares notably higher this week, with the stock gaining roughly 15% since Monday's close. Seeking Alpha analyst Summit Research said on Wednesday that while the Terafab announcement helped boost sentiment for the stock, the "collaboration is likely being over-read, as INTC's anticipated role at the process architecture and design level, rather than as a manufacturing partner, yields a lower revenue share." "Although I see Intel’s latest participation in the Terafab project as incrementally positive, it remains a far cry from what’s needed to maintain durability in the stock’s latest headline-driven rally," added Summit, which has a hold rating on the stock . SA analyst Uttam Dey , meanwhile, downgraded Intel to hold , noting that while the Terafab deal was good news for Intel long term, "Intel's near-term revenue outlook remains flat, with major contributions from Terafab not expected before 2027." "While I am happy about my massive call on Intel last year, I am downgrading my view on Intel to a neutral stance, advising investors to start fading any rally from here on," Dey added. More on Intel Intel: Terafab's Hidden Catch Intel's $25B Terafab Deal - Your Chance To Cash Out Intel: Buying Back The Fab 34 Stake Is Not A Good Idea Chip and AI-related stocks spring as US and Iran agree to temporary ceasefire Intel joins SpaceX, Tesla and xAI in Terafab chip production project
Insiders say activist investors are making greater efforts to engage with companies to affect change from within. Shaun Mathew, partner and head of shareholder activism and hostile takeover defense at Kirkland & Ellis, joins Dani Burger on "Bloomberg Deals" to discuss. (Source: Bloomberg)
Insiders say activist investors are making greater efforts to engage with companies to affect change from within. Shaun Mathew, partner and head of shareholder activism and hostile takeover defense at Kirkland & Ellis, joins Dani Burger on "Bloomberg Deals" to discuss. (Source: Bloomberg)
The post 6 Smart Tax Strategies Investors With $1M+ Are Using to Protect Wealth in 2026 by Benzinga Contributors appeared first on Benzinga . Visit Benzinga to get more great content like this. Schwab research suggests that working with a financial advisor may help some investors improve tax efficiency, though results vary widely based on income, state, fees, and tax-law changes. Instead of search...
The post 6 Smart Tax Strategies Investors With $1M+ Are Using to Protect Wealth in 2026 by Benzinga Contributors appeared first on Benzinga . Visit Benzinga to get more great content like this. Schwab research suggests that working with a financial advisor may help some investors improve tax efficiency, though results vary widely based on income, state, fees, and tax-law changes. Instead of searching for a financial advisor on your own, AdviserMatch asks you a few questions about your goals and situation to pair you with advisors who fit your needs. This can streamline what is otherwise a time-consuming process. AdviserMatch connects individuals with financial advisors who can help with retirement planning, investment strategy, and broader financial guidance. Consultations are no-obligation, and services vary by advisor. It only takes two minutes. 6 Smart Tax Strategies High-Net-Worth Investors Use to Protect Wealth 1. Give your portfolio a strong tax plan Tax exposure is a constant concern for investors, especially those with a diversified portfolio. A 2017 Elsevier study2 found that financial advisors generally have lower portfolio turnover than other advisors, which can help reduce taxes. These advisors will also develop other tax-efficient investing strategies that reduce drag, increase after-tax returns, and make your wealth transfer-ready. Overall, a 2020 Vanguard study3 estimated that certain advisor services could add about 3% in net returns annually for some investors, though results vary and are not guaranteed after fees and market effects. 2. Shelter Your Income and Reduce Your Tax Bill Beyond looking at deductions, a qualified advisor could help high earners implement these tax-saving strategies: Maximize deductions (charitable, mortgage, business expenses) Use tax-advantaged accounts (401(k), IRA, HSA, FSA) Shift into more tax-efficient investments (municipal bonds, ETFs, long-term gains) Restructure your business (LLC, S-Corp, or trust-based strategies...
Forte Biosciences ( FBRX ) has initiated an underwritten public offering of common stock. The company may grant underwriters a 30-day option to buy up to an additional 15% of shares. Proceeds will be used for working capital, clinical development, and research activities. More on Forte Biosciences Forte Biosciences GAAP EPS of -$4.71 Seeking Alpha’s Quant Rating on Forte Biosciences Historical ear...
Forte Biosciences ( FBRX ) has initiated an underwritten public offering of common stock. The company may grant underwriters a 30-day option to buy up to an additional 15% of shares. Proceeds will be used for working capital, clinical development, and research activities. More on Forte Biosciences Forte Biosciences GAAP EPS of -$4.71 Seeking Alpha’s Quant Rating on Forte Biosciences Historical earnings data for Forte Biosciences Financial information for Forte Biosciences
ROCHESTER, N.Y., April 08, 2026 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, reported today its full fiscal year and fourth quarter 2026 financial results. A conference call to discuss the financial results and outlook will be hosted by President and Chief Executive Officer, Bill Newlands, and Executive Vice President and Chief Financial Officer, ...
ROCHESTER, N.Y., April 08, 2026 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, reported today its full fiscal year and fourth quarter 2026 financial results. A conference call to discuss the financial results and outlook will be hosted by President and Chief Executive Officer, Bill Newlands, and Executive Vice President and Chief Financial Officer, Garth Hankinson, on Thursday, April 9, 2026, at 8:00 a.m. ET. Incoming President and CEO Nicholas Fink will also join at the beginning of the call to provide brief remarks before turning the call over to Mr. Newlands and Mr. Hankinson to conduct the question-and-answer session. Visit ir.cbrands.com to locate information for joining the conference call, or a live, listen-only webcast of the conference call.
DALLAS, April 08, 2026 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) (“Applied Digital” or the “Company”) , a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial intelligence, cloud, networking and blockchain workloads, reported financial results for the fiscal third quarter ended February 28, 2026. The Co...
DALLAS, April 08, 2026 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) (“Applied Digital” or the “Company”) , a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial intelligence, cloud, networking and blockchain workloads, reported financial results for the fiscal third quarter ended February 28, 2026. The Company also provided operational updates.
PriceSmart press release ( PSMT ): Q2 GAAP EPS of $1.62 beats by $0.06 . Revenue of $1.50B (+10.3% Y/Y) beats by $20M . Adjusted EBITDA for the second quarter of fiscal year 2026 was $99.7 million compared to $87.0 million in the same period last year. More on PriceSmart PriceSmart's Discount Is Disappearing, But Not Gone Yet PriceSmart Q2 2026 Earnings Preview Quant snapshot: Delta Air Lines lead...
PriceSmart press release ( PSMT ): Q2 GAAP EPS of $1.62 beats by $0.06 . Revenue of $1.50B (+10.3% Y/Y) beats by $20M . Adjusted EBITDA for the second quarter of fiscal year 2026 was $99.7 million compared to $87.0 million in the same period last year. More on PriceSmart PriceSmart's Discount Is Disappearing, But Not Gone Yet PriceSmart Q2 2026 Earnings Preview Quant snapshot: Delta Air Lines leads top-rated names as Byrna Technologies, Simulations Plus lag Seeking Alpha’s Quant Rating on PriceSmart Historical earnings data for PriceSmart
Oracle Corporation (NYSE: ORCL) has received notice of an unsolicited mini-tender offer by TRC Capital Investment Corporation (TRC) dated March 24, 2026, to purchase up to 1,000,000 shares of Oracle's common stock at a price of $140.50 per share in cash. The offer represents less than 0.04% of Oracle's outstanding common stock.
Oracle Corporation (NYSE: ORCL) has received notice of an unsolicited mini-tender offer by TRC Capital Investment Corporation (TRC) dated March 24, 2026, to purchase up to 1,000,000 shares of Oracle's common stock at a price of $140.50 per share in cash. The offer represents less than 0.04% of Oracle's outstanding common stock.